Jianxiang Wang, MD
Institute of Institute of Hematology & Blood Diseases Hospital · Institute of Hematology and Blood Diseases Hospital, Tianjin, China · Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jianxiang Wang, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:14 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07743112 · A Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly Diagnosed Acute Myeloid LeukemiaMaxinovel Pty., Ltd. · recruiting · Acute Myeloid Leukemia · principal investigator
- Ph1NCT07137637 · HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid LeukemiaHangzhou Polymed Biopharmaceuticals, Inc. · recruiting · Relapsed and Refractory Acute Myeloid Leukemia (RR-AML) · principal investigator
- N/ANCT06386302 · Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid LeukemiaInstitute of Hematology & Blood Diseases Hospital, China · recruiting · AML, Acute Myeloid Leukemia · principal investigator
- Ph1/Ph2NCT06206174 · TGRX-814 Chinese Phase I/II in Patients With Hematological MalignanciesShenzhen TargetRx Co., Ltd. · recruiting · Hematologic Malignancy, Non Hodgkin Lymphoma, Acute Myeloid Leukemia · principal investigator
- N/ANCT05801835 · A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for InjectionCSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · unknown · Acute Myeloid Leukemia · principal investigator
- Ph1NCT03913949 · A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic MalignanciesAscentage Pharma Group Inc. · active not recruiting · Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma · principal investigator
- N/ANCT02432872 · Treatment of Older Adult Acute Myeloid Leukemia Patients Aged 55 to 65 YearsJianxiang Wang · unknown · Acute Myeloid Leukemia · principal investigator
- Ph3NCT01633099 · Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia PatientsJianxiang Wang · unknown · Untreated Adult Acute Myeloid Leukemia, Effect of Drugs, Drug Safety · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.